Exicure, Inc. (XCUR) Stock Price & Analysis

Exicure, Inc. (XCUR) rose 0.00% to USD 1.76 as of July 25, 2026 at 04:55 UTC, according to Nexqual real-time market data.

XCUR last closed at USD 1.76; the session ranged USD 1.67–1.76 on volume of 52,889 shares. Market capitalization is —, with a 52-week range of USD 1.43–9.48 (NCM). Source: Nexqual, July 25, 2026 at 04:55 UTC.

Key Statistics (as of July 25, 2026 at 04:55 UTC)

Technical Analysis (XCUR)

Nexqual's technical model rates XCUR "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:55 UTC.

From Exicure, Inc.'s Latest SEC 10-K Filing (filed 2026-03-25)

Key Strengths & Strategy (as disclosed to the SEC)

• Food and Drug Administration (the "FDA") through the New Drug Application ("NDA") process before they may be legally marketed in the United States and are subject to similar requirements in other countries prior to marketing in those countries.
• Our Intellectual Property In our historical business, we built an intellectual property portfolio relating to our prior therapeutic candidates and our SNA technology platform.

Partnerships

• We have no collective bargaining agreement with our employees and we have not experienced any work stoppages.
• In connection with the closing of the Share Purchase Agreement, the Company and GPCR entered into a License and Collaboration Agreement to further develop and commercialize GPCR's technologies related to certain intellectual property and patents.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:55 UTC. This page is informational and not investment advice.